Abvc Biopharma (ABVC) Return on Sales (2016 - 2025)
Historic Return on Sales for Abvc Biopharma (ABVC) over the last 14 years, with Q3 2025 value amounting to 1.62%.
- Abvc Biopharma's Return on Sales fell 3700.0% to 1.62% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.37%, marking a year-over-year decrease of 22400.0%. This contributed to the annual value of 10.32% for FY2024, which is 440100.0% up from last year.
- According to the latest figures from Q3 2025, Abvc Biopharma's Return on Sales is 1.62%, which was down 3700.0% from 18.03% recorded in Q2 2025.
- In the past 5 years, Abvc Biopharma's Return on Sales registered a high of 18.03% during Q2 2025, and its lowest value of 2429.6% during Q1 2024.
- For the 5-year period, Abvc Biopharma's Return on Sales averaged around 219.24%, with its median value being 14.79% (2023).
- As far as peak fluctuations go, Abvc Biopharma's Return on Sales tumbled by -24148100bps in 2024, and later skyrocketed by 24336200bps in 2025.
- Abvc Biopharma's Return on Sales (Quarter) stood at 17.53% in 2021, then crashed by -144bps to 7.64% in 2022, then tumbled by -4133bps to 323.47% in 2023, then decreased by -25bps to 405.15% in 2024, then soared by 100bps to 1.62% in 2025.
- Its Return on Sales stands at 1.62% for Q3 2025, versus 18.03% for Q2 2025 and 4.02% for Q1 2025.